FFA
PASG icon

Farther Finance Advisors’s Passage Bio PASG Stock Holding History

Farther Finance Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$19 – 4622
2025
Q1 		$19 Hold
3
– – ﹤0.01% 4193
2024
Q4 		$28 Buy
+3
New +$39 ﹤0.01% 3919

Other funds holding PASG

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Farther Finance Advisors's PASG Position: Q2 2025 in Review

Farther Finance Advisors sold out of Passage Bio (PASG) in Q2 2025, closing a stake of 3 shares — an estimated $19 sold.

Farther Finance Advisors first reported a position in PASG in Q4 2024 and held it in 2 quarters. The position peaked at $28 in Q4 2024. 39 funds tracked by Wall St. Rank hold PASG as of Q2 2025.

  • Farther Finance Advisors reported no remaining Passage Bio position as of Q2 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 3 Passage Bio shares in Q2 2025, an estimated $19.
  • Farther Finance Advisors first reported a position in Passage Bio in Q4 2024 and held it in 2 quarters.
  • Farther Finance Advisors's Passage Bio position peaked at $28 in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Passage Bio as of Q2 2025.

Based on Farther Finance Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.